Our previous study demonstrated an anticancer effect on luminal A breast cancer by calcium-dependent Src degradation based on the background that estrogen binding to ER can promote rapid and transient interactions with cellular Src for activation of survival signaling [13]. Here, ESR1 is linked to breast carcinoma.